CRIS Current Research Information System

GIANNINI, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.917
EU - Europa 2.100
AS - Asia 1.804
AF - Africa 169
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 9.007
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.901
DE - Germania 608
CN - Cina 567
SG - Singapore 485
GB - Regno Unito 479
VN - Vietnam 343
IN - India 313
SE - Svezia 254
IT - Italia 213
IE - Irlanda 165
FR - Francia 132
TG - Togo 108
RU - Federazione Russa 99
ZA - Sudafrica 41
CH - Svizzera 36
FI - Finlandia 24
HK - Hong Kong 23
ID - Indonesia 22
CI - Costa d'Avorio 19
BG - Bulgaria 18
BE - Belgio 12
UA - Ucraina 11
AT - Austria 10
JP - Giappone 10
ES - Italia 9
CA - Canada 8
IL - Israele 7
PL - Polonia 7
RO - Romania 7
TR - Turchia 7
BR - Brasile 6
JO - Giordania 6
AE - Emirati Arabi Uniti 4
GR - Grecia 4
IR - Iran 4
LB - Libano 4
NL - Olanda 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
MX - Messico 3
BZ - Belize 2
CL - Cile 2
CU - Cuba 2
KR - Corea 2
MY - Malesia 2
UZ - Uzbekistan 2
AR - Argentina 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
TH - Thailandia 1
Totale 9.007
Salva come PNG Salva come JPEG
Città #
Chandler 693
Santa Clara 436
Southend 434
Singapore 426
Fairfield 395
Ashburn 356
Princeton 278
Dong Ket 239
Wilmington 237
Woodbridge 230
Houston 225
Boardman 184
Seattle 183
Dublin 164
Ann Arbor 160
Cambridge 141
Lomé 108
Berlin 105
Westminster 99
Des Moines 80
Jinan 54
Beijing 49
Bologna 43
Falls Church 33
New York 33
San Diego 32
Bern 30
Pune 29
Helsinki 22
Jakarta 22
Milan 22
Nanjing 21
Shanghai 21
Shenzhen 21
Zhengzhou 21
Abidjan 19
Redwood City 19
Hong Kong 17
Sofia 17
London 16
Medford 16
Paris 15
Rochester 15
Taiyuan 15
Bühl 14
Chicago 13
Norwalk 13
Brussels 12
Changsha 12
Hangzhou 12
Mülheim 12
Naples 12
Phoenix 12
Fuzhou 10
Los Angeles 10
Redmond 9
Shenyang 9
Wenzhou 9
Las Vegas 8
Olalla 8
Saint Petersburg 8
San Jose 8
Wuhan 8
Frankfurt am Main 7
Guangzhou 7
Haikou 7
Harbin 7
Hebei 7
Xi'an 7
Amman 6
Foshan 6
Istanbul 6
Lanzhou 6
Moscow 6
Rome 6
Taizhou 6
Tianjin 6
Boydton 5
Genoa 5
Kilburn 5
Kyoto 5
Ningbo 5
St Louis 5
Vancouver 5
Caserta 4
Chengdu 4
Chongqing 4
Dongguan 4
Dubai 4
Falkenstein 4
Hyderabad 4
Tel Aviv 4
Trento 4
Albuquerque 3
Ariccia 3
Forlì 3
Handan 3
Leawood 3
Ludwigshafen 3
Mexico City 3
Totale 6.156
Salva come PNG Salva come JPEG
Nome #
Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre 166
Brain ischemic injury in COVID-19-infected patients: a series of 10 post-mortem cases 122
Rare primary non-neuroendocrine tumours of the sella 104
Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas 103
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT 100
Advances in multidisciplinary therapy for meningiomas 99
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading 99
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma 96
A 21-year-old woman with multiple cancers and a new brain lesion 94
Heterogeneity within the PF-EPN-B ependymoma subgroup 92
Primary central nervous system vasculitis associated with lymphoma 90
Anaplastic Ependymoma and Posterior Fossa Grouping in a Patient With H3K27ME3 Loss of Expression but Chromosomal Imbalance 90
Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas 88
Life after surgical resection of a meningioma: A prospective cross-sectional study evaluating health-related quality of life 87
Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration 87
Chordoma of the corpus callosum: Case report 87
Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia 85
Adult patients with supratentorial pilocytic astrocytoma: Long-term follow-up of ospective multicenter clinical trial NCCTG-867251 (alliance) 82
Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis 82
Primary central nervous system vasculitis mimicking brain tumor: Comprehensive analysis of 13 cases from a single institutional cohort of 191 cases 80
Plenty of calcification: imaging characterization of polymorphous low-grade neuroepithelial tumor of the young 80
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma 79
Glioblastoma of the cerebellopontine angle and internal auditory canal mimicking a peripheral nerve sheath tumor: Case report 79
Telomere alterations in neurofibromatosis type 1-associated solid tumors 79
International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading 79
Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy-Related Inflammation 79
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas 79
cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC) 78
Inflammatory cortical demyelination in early multiple sclerosis 78
A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872 78
Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation 77
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility 77
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 77
2016 updates to the WHO brain tumor classification system: What the radiologist needs to know 77
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial 76
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG) 76
Low-grade fibromyxoid sarcoma arising within the median nerve 75
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations 75
Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior 75
Intracranial myxoid mesenchymal tumors with EWSR1–CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity? 74
Gliomas in neurofibromatosis type 1: A clinicopathologic study of 100 patients 74
Intertumoral Heterogeneity within Medulloblastoma Subgroups 74
Glioneuronal Heterotopia Presenting as Cerebellopontine Angle Tumor of Cranial Nerve VIII 73
A pediatric intra-axial malignant smarcb1-deficient desmo-plastic tumor arising in meningioangiomatosis 73
24-Year-Old Woman with Recent Onset Back Pain 73
Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association 71
Imaging and diagnostic advances for intracranial meningiomas 71
The impact of histopathology and NAB2–STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma 71
Venous congestive myelopathy: a mimic of neoplasia 71
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis 70
MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism 70
Molecular and translational advances in meningiomas 70
Bilateral generalized polymicrogyria (BGP) - A distinct syndrome of cortical malformation 69
Molecular profiling of long-term IDH-wildtype glioblastoma survivors 69
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma 69
Case-based review: Primary central nervous system lymphoma 68
Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572 66
Adenoid Cystic Carcinoma Metastatic to the Pituitary: A Case Report and Discussion of Potential Diagnostic Value of Magnetic Resonance Elastography in Pituitary Tumors 66
Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors 66
Diagnostic and Therapeutic Strategy in Anaplastic (Malignant) Meningioma, CNS WHO Grade 3 66
Can intraneural perineuriomas occur intradurally? An anatomic perspective 65
DNA methylation profiling to predict recurrence risk in meningioma: Development and validation of a nomogram to optimize clinical management 65
Case-based review: Newly diagnosed glioblastoma 65
Cavernous Hemangiomas of the Internal Auditory Canal and Cerebellopontine Angle 65
Adult primary central nervous system vasculitis treatment and course: Analysis of one hundred sixty-three patients 65
Primary papillary epithelial tumour of the sella: expanding the spectrum of TTF-1-positive sellar lesions 64
Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients 63
Pilocytic astrocytoma: pathology, molecular mechanisms and markers 63
Long-term remission, relapses and maintenance therapy in adult primary central nervous system vasculitis: A single-center 35-year experience 63
Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data 62
An Update of the Mayo Clinic Cohort of Patients with Adult Primary Central Nervous System Vasculitis 62
Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis 62
Ewing Sarcoma in Older Adults: A Clinicopathologic Study of 50 Cases Occurring in Patients Aged ≥40 Years, With Emphasis on Histologic Mimics 62
Genomic and phenotypic characterization of a broad panel of patient-derived xenografts reflects the diversity of glioblastoma 61
The dangers of the “Head Down” position in patients with untreated pituitary macroadenomas: case series and review of literature 60
Constitutive interferon pathway activation in tumors as an efficacy determinant following oncolytic virotherapy 60
cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant 60
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme 60
FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma 59
Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma 59
Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis 59
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients 59
Pleomorphic xanthoastrocytoma: Natural history and long-term follow-up 58
Combined infiltrating astrocytoma/pleomorphic xanthoastrocytoma harboring IDH1 R132H and BRAF V600E mutations 57
Concomitant 1p/19q co-deletion and IDH1/2, ATRX, and TP53 mutations within a single clone of “dual-genotype” IDH-mutant infiltrating gliomas 56
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13 56
Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas 54
Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3) 54
Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma 54
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets 53
Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults 53
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma 53
Management of diffuse low-grade gliomas in adults - Use of molecular diagnostics 52
A revised diagnostic classification of canine glioma: Towards validation of the canine glioma patient as a naturally occurring preclinical model for human glioma 51
Using germline variants to estimate glioma and subtype risks 51
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: Results of Alliance N0874/ABTC 02 50
TTF-1 positive posterior pituitary tumor: Limitations of current treatment and potential new hope in BRAF V600E mutation variants 49
TERT promoter mutation: is it enough to call a WHO grade II astrocytoma IDH wild-type glioblastoma? 49
WHO 2016 classification: changes and advancements in the diagnosis of miscellaneous primary CNS tumours 48
Synchronous Tumors of the Cerebellopontine Angle 48
Totale 7.189
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.610
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.035 0 0 0 0 0 5 8 317 343 192 114 56
2020/20211.478 261 78 39 22 31 147 185 93 86 60 42 434
2021/20221.880 118 18 130 24 258 120 49 201 105 228 257 372
2022/20232.529 306 441 115 274 199 174 81 162 331 108 155 183
2023/2024600 41 133 36 36 66 87 49 35 20 39 44 14
2024/20251.838 52 467 230 262 659 168 0 0 0 0 0 0
Totale 9.385